Announcements Trials

Browse Landscape

Phase

Phase 2 10 Phase 3 3 Phase NA 1 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Specimen Handling 49 pembrolizumab 44 Magnetic Resonance Spectroscopy 37 Biopsy 35 Cyclophosphamide 33 fludarabine 28 Cetuximab 20 Cisplatin 19 Carboplatin 19 Bevacizumab 16 atezolizumab 15 Radiation 15 venetoclax 14 Fluorouracil 14 fludarabine phosphate 13 Radiotherapy 13 Leucovorin 13 Nivolumab 12 Gemcitabine 12 Pemetrexed 11 Oxaliplatin 11 Cytarabine 11 Irinotecan 10 130-nm albumin-bound paclitaxel 10 Prednisone 9 Paclitaxel 9 Immunoglobulin G 9 Fulvestrant 9 durvalumab 8 Temozolomide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Phantoms, Imaging × 30 days × Clear all

NCT03842228 2026-05-29

COD

National Cancer Institute (NCI)

Phase 1 Active not recruiting

39 enrolled 15 charts

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡